|
|
| MRD / Regn No. |
: 20190000384 |
Date |
: 02/07/2026 |
| Patient Name |
: Saravanan Pillappan |
Age & Gender |
: 39 Yrs. / Male |
| Contact No. |
: 9444891222 |
UHID |
: |
| Ht / Wt / BMI |
: 177.5 / 102.7 / 32.60 |
BP S / BP D |
: 122 / 83 |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
MILD TSH ELEVATION (19/Jun/2019) | VITAMIN D DEFICIENCY (20/Jun/2019) | |
|
Subjective |
: |
LOST TO FOLLOW UP,DM SINCE 2024,NOT ON MEDICATIONS,DYSLIPIDEMIA |
|
Objective |
: |
N |
|
Analysis |
: |
TYPE 2 DM,OBESITY,MILD TSH ELEVATION |
|
Plan |
: |
INCREASE TIRZEPATIDE TO 5 MG,SEE ME IN 1 MONTH |
|
| Salient Investigations |
: |
FASTING PLASMA GLUCOSE (FPG): 86.6 mg/dL | POST PRANDIAL GLUCOSE (2HPP): 84.2 mg/dL | |
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
CHOLECALCIFEROL 2000 IU
D RISE 2000 IU |
PO |
0-0-1 |
AFTER FOOD
|
TILL NEXT VISIT |
| TAKE AT BEDTIME | |
|
2 |
SGLT2I EMPAGLIFLOZIN 10 MG
JARDIANCE
Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION |
PO |
1-0-0 |
BEFORE FOOD
|
TILL NEXT VISIT |
| MAY CAUSE GENITOURINARY INFECTIONS | |
|
3 |
INJECTION TIRZEPATIDE 5 MG
MOUNJARO
Medicine For OBESITY DIABETES |
SQ |
ONCE A WEEK |
AS DIRECTED NO RELATION TO FOOD
|
TILL NEXT VISIT |
| MAY CAUSE NAUSEA VOMITING OR DIARRHEA | |
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 01/Aug/2026 |
| Tests Suggested For Next Visit |
: FBS 2HPP BUN CR |
| |
|
| |
|
|
